Even if they are making $20 to $25 per kit. 1.5mil kits sold already to NG Biotech that is $30 to $37.5mil in revenue plus more to come in Aus/NZ and Asia.
may be not a good announcement for traders but looking very positive for medium to long term
Ann: Atomo and NG Biotech expand COVID-19 partnership, page-41
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.001(4.55%) |
Mkt cap ! $13.42M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.2¢ | 2.1¢ | $4.534K | 206.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 205762 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 181965 | 2 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| AT1 (ASX) Chart |